Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Nature Communications|November 3, 2021
C-Glycoside metabolism in the gut and in nature: Identification, characterization, structural analyses and distribution of C-C bond-cleaving enzymesTakahiro Mori, Takuto Kumano, Haibing He, et al.
Oncotarget|October 22, 2016
Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1Yoshikane Nonagase, Kimio Yonesaka, Hisato Kawakami, et al.
BMC Cancer|October 18, 2019
Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancerTsutomu Iwasa, Junji Tsurutani, Satomi Watanabe, et al.
Scientific Reports|December 22, 2019
Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitorsKimio Yonesaka, Eiji Iwama, Hidetoshi Hayashi, et al.
Cancer Research Communications|March 11, 2026
Constitutive EGFR activation induced by PTPRR downregulation confers resistance to KRAS inhibitorsHiroaki Kanemura, Toshiyuki Takehara, Osamu Maenishi, et al.
Future Oncology (London, England)|April 15, 2026
Phase II basket study of brigatinib for ALK fusion-positive solid tumors: WJOG15221M/ALLBREAK (a decentralized clinical trial design)Tomoki Sakakida, Toshiki Masuishi, Takuma Onoe, et al.
Scientific Reports|August 7, 2019
A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencingKazuko Sakai, Masayuki Takeda, Shigeki Shimizu, et al.
Breast Cancer Research and Treatment|July 20, 2026
Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B)Meiko Nishimura, Takahiro Kogawa, Keiji Sugiyama, et al.
The Oncologist|December 16, 2020
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid TumorsMasayuki Takeda, Takayuki Takahama, Kazuko Sakai, et al.
Pageof 3